Key points are not available for this paper at this time.
A nickel-catalyzed reductive cross coupling with phosphonium salts and allylic C(sp3)–O bond electrophiles, which granted direct construction of the C(sp2)–C(sp3) bond, is successfully developed. The protocol features broad substrate scope, high-functional-group tolerance, and heterocycle compatibility. Notably, the much more challenging reductive cross coupling with heterocyclic thiazolylphosphonium salts has also been accomplished for the first time.
Wang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: